Michael Makris: When a Researcher Is Listed as First Author Without Knowing
Michael Makris, Emeritus Professor of Haemostasis and Thrombosis at University of Sheffield, Editor-in-Chief of Research and Practice in Thrombosis and Haemostasis, shared Eric Topol‘s post on LinkedIn:
“This is incredible.
The first author had nothing to do with this paper, and he was added as the main author without his consent!
I note that the corresponding author lists their position at a prestigious US university.
Vanderbilt University has a moral and scientific obligation to investigate and openly report back to the scientific community about what happened here.
The journal and its publisher should also issue a statement about their policies and what went wrong in this case.”
Eric Topol, Founder and Director of Scripps Research Translational Institute, shared a post on LinkedIn:
“This is a fraudulent paper, AI-generated.
My name was used as an author and I had nothing to do with it, never saw it until today.
The ‘Editors’ Angelo Rossi Mori, David Mensah, and Zarnie Khadjesari and this ‘Journal’ should be reported.”
Other posts featuring Michael Makris and Eric Topol on Hemostasis Today.
-
Apr 24, 2026, 09:08Erica Sparkenbaugh: The Women Behind the UNC’s 12th Hemostasis Symposium
-
Apr 24, 2026, 08:34Akmez Latona: Clauss vs PT-Derived Fibrinogen in Relation to Viscoelastic Clot Strength
-
Apr 24, 2026, 08:20Jack Shuang Hou: CorTec Wins FDA TAP Entry for Brain Interchange
-
Apr 24, 2026, 08:13Prasen Marella Highlights Recruitment Challenges in Stroke-Alzheimer’s Research at TS26 – UTHealth Houston Stroke
-
Apr 24, 2026, 08:03Shayla Kassam: Canadian Stroke Consortium’s Climate and Health Sustainability Policy is Officially Live Now
-
Apr 24, 2026, 07:49Heroine Helen Saves Stroke Victim’s Life – Eastlight Community Homes
-
Apr 24, 2026, 07:45Marilena Vrana: Insights from the Alpha-1 Alliance Event on Advancing Plasma Access in the EU
-
Apr 24, 2026, 07:36Sanjoy Deb: Bridging the Gap in Post-Stroke Nutrition Support for Survivors and Carers
-
Apr 24, 2026, 07:13William Cadden: Risk–Benefit Considerations in Atrial Fibrillation